1. The Mexican consensus on nonalcoholic fatty liver disease
- Author
-
Bernal Reyes, R., Castro Narro, Graciela, Male Velázquez, Rene, Carmona Sánchez, R.I., González Huezo, M. S., García Juárez, I., Chávez Tapia, Norberto C., Aguilar Salinas, Carlos Alberto, Aiza Haddad, Ignacio, Ballesteros Amozurrutia, Mario Arturo, Bosques Padilla, Francisco Javier, Castillo Barradas, M., Chávez Barrera, J. A., Cisneros Garza, Laura Esthela, Flores Calderón, J., García Compeán, Diego, Gutiérrez Grobe, Y., Higuera de la Tijera, María de Fátima, Kershenobich Stalnikowitz, David, Ladrón de Guevara Cetina, L., Lizardi Cervera, J., López Cossio, J.A., Martínez Vázquez, S., Márquez Guillén, E., Méndez Sánchez, N., Moreno Alcántar, R., Poo Ramírez, J.L., Ramos Martínez, P., Rodríguez Hernández, Heriberto, Sánchez Ávila, Juan F., Stoopen Rometti, M., Torre Delgadillo, A., Torres Villalobos, G., Trejo Estrada, Rafael, Uribe Esquivel, M., Velarde Ruiz Velasco, José Antonio, Bernal Reyes, R., Castro Narro, Graciela, Male Velázquez, Rene, Carmona Sánchez, R.I., González Huezo, M. S., García Juárez, I., Chávez Tapia, Norberto C., Aguilar Salinas, Carlos Alberto, Aiza Haddad, Ignacio, Ballesteros Amozurrutia, Mario Arturo, Bosques Padilla, Francisco Javier, Castillo Barradas, M., Chávez Barrera, J. A., Cisneros Garza, Laura Esthela, Flores Calderón, J., García Compeán, Diego, Gutiérrez Grobe, Y., Higuera de la Tijera, María de Fátima, Kershenobich Stalnikowitz, David, Ladrón de Guevara Cetina, L., Lizardi Cervera, J., López Cossio, J.A., Martínez Vázquez, S., Márquez Guillén, E., Méndez Sánchez, N., Moreno Alcántar, R., Poo Ramírez, J.L., Ramos Martínez, P., Rodríguez Hernández, Heriberto, Sánchez Ávila, Juan F., Stoopen Rometti, M., Torre Delgadillo, A., Torres Villalobos, G., Trejo Estrada, Rafael, Uribe Esquivel, M., and Velarde Ruiz Velasco, José Antonio
- Abstract
Nonalcoholic fatty liver disease (NAFLD) affects nearly one third of the population worldwide. Mexico is one of the countries whose population has several risk factors for the disease and its prevalence could surpass 50%. If immediate action is not taken to counteract what is now considered a national health problem, the medium-term panorama will be very bleak.This serious situation prompted the Asociación Mexicana de Gastroenterología and the Asociación Mexicana de Hepatología to produce the Mexican Consensus on Fatty Liver Disease. It is an up-to-date and detailed review of the epidemiology, pathophysiology, clinical forms, diagnosis, and treatment of the disease, whose aim is to provide the Mexican physician with a useful tool for the prevention and management of nonalcoholic fatty liver disease.
- Published
- 2019